News Posts List
Advances in Cancer Research
12/07/2011
Dr. Vogelzang is a founding member and director of the Kidney Cancer Association.
Unanimous Support for Pfizer's Inlyta
12/07/2011
Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.
FDA Panel to Consider New Kidney Cancer Drug
12/05/2011
A Business Week Article gives the appearance that FDA might not like this drug, but is it effectiveness or cost that is driving this? FDA recently pulled its approval for Avastin in breast cancer, a drug also used to treat advanced kidney cancer. Some critics thought the cost of the therapy was really at issue.
Generation of anti-tumour immune response using dendritic cells
12/04/2011
This fusion protein was capable of inducing DC maturation and interleukin (IL)-12 production in DCs. Interaction of DCs pulsed with CA9-AbOmpA fusion proteins with naive T cells stimulated secretion of IL-2, interferon (IFN)-γ and tumour necrosis factor (TNF)-α in T cells.
What's it like to be a young adult with kidney cancer?
12/02/2011
What's it like to be a young adult diagnosed with kidney cancer?
Kidney Cancer News for December 2011
12/02/2011
The final broadcast of Kidney Cancer News for 2011 examines the importance of advanced surgical techniques in the treatment of renal cancers. It features Dr. Matin who spoke at the Kidney Cancer Association's National Patients and Survivors Conference held in Houston at M. D. Anderson Cancer Center.
A Phase I Study of Dasatinib in Combination With Bevacizumab
12/01/2011
This is a dose-escalation study of dasatinib and bevacizumab (Group 1) followed by a randomized study (Group 2). The dose-escalation phase of the study has been completed. Group 2 is now enrolling.
Common Household Product Ingredient Linked to Cancer
12/01/2011
Scientists from Nanyang Technological University (NTU) have found a possible link between a popular ingredient in cosmetics and cancer.
News Feed